Somatic mutations leading to MET exon 14 splicing have been shown to occur in approximately 3% of NSCLC [1] cases, with a higher frequency observed in primary sarcomatoid carcinomas (SC) of the lung [4], although reports were based on highly variable cohort sizes and sequencing technologies (Table 1). This evidence concerns the gene MET and non-small cell lung carcinoma.